Arthneeti
MP

Mukka Proteins Ltd

Q2 FY27Food Products

Mukka Proteins Q2 Results 2026 (FY27) statement: Revenue & Margins

Q2 FY27 results statement: what the company reported on revenue, margins and capex.

Revenue
₹509Cr
Net profit
₹18Cr
Margin
8.3%

Mukka Proteins Ltd Q2 FY27 key numbers

Revenue
Total income for the quarter was Rs. 5,179.08 million, up from Rs. 2,505.81 million in the corresponding quarter of the previous year.

As stated in Mukka Proteins Ltd's Q2 FY27 results statement · published 7 Nov 2026. Reported figures, not investment advice.

Based on Mukka Proteins Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

Price₹27
Market cap₹821 Cr
P/E11.9

The short version

Revenue from operations for the quarter ended September 30, 2026 was Rs. 4,952.82 million, compared to Rs. 2,360.81 million for the quarter ended September 30, 2025, representing a year-on-year increa. Quarter ended September 30, 2026 (Standalone):.

From Mukka Proteins Ltd's Q2 FY27 earnings-call transcript · updated 7 Nov 2026.

How did Mukka Proteins' revenue grow in the September 2026 quarter?

- Revenue from operations for the quarter ended September 30, 2026 was Rs. 4,952.82 million, compared to Rs. 2,360.81 million for the quarter ended September 30, 2025, representing a year-on-year increase of approximately 110%. - Total income for the quarter was Rs. 5,179.08 million, up from Rs. 2,505.81 million in the corresponding quarter of the previous year. Summary: The presentation reports a significant year-on-year revenue growth of around 110% for the quarter.

What happened to Mukka Proteins' margins in Q2 FY27?

See what Mukka Proteins Ltd said on profitability & margins — free account, 30 seconds.

What capex is Mukka Proteins planning?

  • Financial statements indicate capital work-in-progress amounts of Rs. 47.28 million (Standalone Sept 2026) and Rs. 225.23 million (Consolidated Sept 2026), suggesting ongoing investments.
  • Purchase of fixed assets and capital works in progress totaled Rs. 320.88 million for the half year ended Sept 30, 2026 (Consolidated), showing active capex.
  • The Board approved a strategic investment of Rs. 2.13 crores in Swaccha Eco Solutions Private Limited (SESPL) to expand the company’s waste management segment, but this is an acquisition, not capex or capacity expansion.

Top-ranked in Food Products

Ranked on what management guided this quarter

Guidance-ranked
1Nurture Well Industries
Rev 1Mar 1
2Hoac Foods
Rev 1Mar 1
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Mukka Proteins raising money or cutting debt?

See what Mukka Proteins Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Mukka Proteins' order book?

See what Mukka Proteins Ltd said on order book & pipeline — free account, 30 seconds.

Mukka Proteins Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Mukka Proteins Ltd Q2 FY27 results — key figures

Mukka Proteins Ltd Q2 FY27 reported results vs year-ago quarter, ₹ crore
₹ CrQ2 FY27
Revenue509
Operating profit (EBITDA)42
Operating margin8.3%
Profit before tax29
Net profit (PAT)18
EPS (₹)0.53

Source: Mukka Proteins Ltd's results filing to NSE (consolidated), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹509 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Mukka Proteins's management said in earlier quarters

Others in Food Products this season

  • Sheetal Cool (Q2 FY27)

    17%) . Key results statement takeaways from Sheetal Cool Products Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Shri Ahimsa (Q2 FY27)

    Revenue from operations for the half year ended 30th September 2026: ₹8,005.14 lakhs, compared to ₹6,051.72 lakhs for the half year ended 30th September 2025…

  • Kwality Wall's (Q2 FY27)

    42.1% increase) . Key results statement takeaways from Kwality Walls India Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Sundrop Brands (Q2 FY27)

    Q2 FY27 revenue from operations: INR 463.1 crore, up 21% YoY from INR 383.3 crore (Page 12). Key investor presentation takeaways from Sundrop Brands Ltd's Q2 FY

Compare:vs Nestle Indiavs Britannia Industriesvs Hatsun Agro

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Mukka Proteins Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Mukka Proteins Ltd Q2 FY27 results?

Revenue from operations for the quarter ended September 30, 2026 was Rs. 4,952.82 million, compared to Rs. 2,360.81 million for the quarter ended September 30, 2025, representing a year-on-year increa. Quarter ended September 30, 2026 (Standalone):.

What is Mukka Proteins Ltd share price analysis?

Mukka Proteins Ltd currently shows a neutral. The stock trades at a P/E of 11.9 with a market cap of ₹821 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Mukka Proteins Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.